Lenvatinib Mesilate Capsules
Product Description
Jiangsu Simcere Pharmaceutical Co., Ltd.
-
CN
-
2019On CPHI since
-
5000+Employees
Company types
Categories
Jiangsu Simcere Pharmaceutical Co., Ltd.
-
CN
-
2019On CPHI since
-
5000+Employees
Company types
More Products from Jiangsu Simcere Pharmaceutical Co., Ltd. (2)
-
Product Enlength
As a cornerstone drug for the treatment of multiple myeloma, Bortezomib is used throughout the induction, consolidation and maintenance therapies for myeloma. In 2020, Bortezomib was recommended as a first-line drug for the full management of multiple myeloma in the Guidelines for Diagnosis and Treatm... -
Product Sanbexin
Sanbexin is indicated for the improvement of neurological symptoms, activities of daily living and dysfunction caused by acute cerebral infarction. Category 1 innovative drug with solid medical evidence support. It takes only 5 months from launch to NRDL list. It can improve the neurological function o...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance